ECSP003353A - PROTEASE INHIBITORS IX - Google Patents
PROTEASE INHIBITORS IXInfo
- Publication number
- ECSP003353A ECSP003353A ECSP003353A ECSP003353A EC SP003353 A ECSP003353 A EC SP003353A EC SP003353 A ECSP003353 A EC SP003353A EC SP003353 A ECSP003353 A EC SP003353A
- Authority
- EC
- Ecuador
- Prior art keywords
- excessive
- compounds
- disease
- matrix degradation
- present
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 206010065687 Bone loss Diseases 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 230000015556 catabolic process Effects 0.000 abstract 2
- 238000006731 degradation reaction Methods 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 208000030136 Marchiafava-Bignami Disease Diseases 0.000 abstract 1
- 208000029725 Metabolic bone disease Diseases 0.000 abstract 1
- 208000010191 Osteitis Deformans Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000027868 Paget disease Diseases 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- -1 captesin K Substances 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001033 ether group Chemical group 0.000 abstract 1
- 208000024693 gingival disease Diseases 0.000 abstract 1
- 208000007565 gingivitis Diseases 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 230000000148 hypercalcaemia Effects 0.000 abstract 1
- 208000030915 hypercalcemia disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 208000027202 mammary Paget disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 201000001245 periodontitis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El presente invento proporciona inhibidores de proteasas con estructura de éteres anulares de 7 14 miembros y sales, hidratos y solvatos farmacéuticamente aceptables de los mismos, que inhiben proteasa, incluyendo la captesina K composiciones framacéuticas de dichos compuestos: nuevos productos intermedios de dichos compuestos y métodos para tratar enfermedades por una excesiva pérdida ósea o una excesiva degradación carrilaginosa o matricial, incluyendo osteoporosis, enfermedades gingivales que incluyen gingivitis y periodontitis, artritis, más especificamente osteoartritis y artritis reumatoide, enfermedad de Paget, hipercalcemia maligna y enfermedad ósea metabólica, que comprenden inhibir dicha pérdida ósea o dicha excesiva degradación cartilaginosa o matricial mediante la administración de un compuesto del presente invencto a un paciente que lo necesita.The present invention provides proteases inhibitors with 7 14-membered ring ether structures and pharmaceutically acceptable salts, hydrates and solvates thereof, which inhibit protease, including captesin K, pharmaceutical compositions of said compounds: novel intermediates of said compounds and methods. to treat diseases of excessive bone loss or excessive carilaginous or matrix degradation, including osteoporosis, gingival diseases including gingivitis and periodontitis, arthritis, more specifically osteoarthritis and rheumatoid arthritis, Paget's disease, malignant hypercalcemia and metabolic bone disease, comprising inhibiting said bone loss or said excessive cartilage or matrix degradation by administering a compound of the present invention to a patient in need.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003353 ECSP003353A (en) | 2000-02-17 | 2000-02-17 | PROTEASE INHIBITORS IX |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003353 ECSP003353A (en) | 2000-02-17 | 2000-02-17 | PROTEASE INHIBITORS IX |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003353A true ECSP003353A (en) | 2000-06-19 |
Family
ID=42040984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003353 ECSP003353A (en) | 2000-02-17 | 2000-02-17 | PROTEASE INHIBITORS IX |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003353A (en) |
-
2000
- 2000-02-17 EC ECSP003353 patent/ECSP003353A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26625A1 (en) | PROTEASE INHIBITORS | |
| NO20013124L (en) | Protease inhibitors | |
| AP9801222A0 (en) | Proatease inhibitors. | |
| UY27700A1 (en) | OXO COMPOUNDS - AZABYCLES. | |
| PA8589701A1 (en) | SUBSTITUTED UREAS AND USEFUL CARBAMATES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| BR9809333A (en) | Protease inhibitors | |
| MXPA02012442A (en) | Protease inhibitors. | |
| WO1999059526A3 (en) | Protease inhibitors | |
| UY26026A1 (en) | PROTEASE INHIBITORS | |
| HK1042695A1 (en) | Prothease inhibitors | |
| UY26088A1 (en) | PROTEASE INHIBITORS | |
| HK1041690A1 (en) | Protease inhibitors | |
| ECSP003353A (en) | PROTEASE INHIBITORS IX | |
| UY27032A1 (en) | PROTEASE INHIBITORS | |
| WO2002092563A3 (en) | Protease inhibitors | |
| UY26771A1 (en) | PROTEASE INHIBITORS | |
| ECSP992959A (en) | BIS-AMINOMETIL CARBONYL PROTEASE INHIBITORS | |
| ECSP003403A (en) | PROTEASE INHIBITORS XI | |
| AR021971A1 (en) | PROTEASE INHIBITORS | |
| ECSP993293A (en) | PROTEASE INHIBITORS VIII | |
| ECSP982493A (en) | PROTEASE INHIBITORS III | |
| ECSP982486A (en) | PROTEASE INHIBITORS II | |
| ECSP982481A (en) | PROTEASE INHIBITORS | |
| PA8541201A1 (en) | GLYCIN, N- [N-L-GAMMA-GLUTAMIL-3- (NITROSOTIO) -L-VALIL] AND ITS APPLICATIONS | |
| AR004703A1 (en) | HYDRAZIDIL, BIS-HYDRAZIL AND BIS-AMINOMETIL-CARBONIL, PROTEASE INHIBITORS, A PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING PROTEASES, AND USE IN THE PREPARATION OF MEDICINES. |